Search results Search for: Search Refine your results by duration: Any Under 5 mins Under 20 mins Over 20 mins Sort by: Relevance Views Date Variability, Limits, and Other Considerations for the Next Generation... Karen Zink McCullough, Kevin L Williams, Nicola Reid, Veronika Wills and Allen L. Burgenson, Full title: Variability, Limits, and Other Considerations for the Next Generation of Pyrogen and Endotoxin Testing The Limulus Amebocyte Lysate (LAL... 4 months ago | 174 mins Considerations For Sterility Test Methods When Working With CDMOs Miriam Guest at AstraZeneca, Anne Weeks at Merck KGaA and Chris Berridge at Ecolab The confirmation of microbial quality of drug products manufactured by contract manufacturing organisations (CMOs) is a key component of product relea... September 14, 2023 2:00pm New Tools to Assess the Risk of Microbial Impurities in the Pharmaceutical... Presented by Friedrich von Wintzingerode Global QC at Roche Followed by Mathilde Arnault, Research Scientist at Merck KGaA, Full Title: New Tools to Assess the Risk of Microbial Impurities in the Pharmaceutical Manufacturing Process Large scale Production of Biologics is s... 4 years ago | 62 mins The Situation of Antimicrobial Resistance in Europe Professor Gian Maria Rossolini Antimicrobial resistance exhibits remarkable diversity in the European population, providing opportunities to explore both trends and testing. In this... 5 years ago | 26 mins Rapid methods- The Next Phase : A Framework For Multi-Product Adoption... Miriam Guest, at AstraZeneca UK and Ulrich Herber at Charles River Full Title: Rapid methods- The Next Phase : A Framework For Multi-Product Adoption Of Rapid Sterility Testing The adoption of rapid sterility testing... 1 year ago | 120 mins Rapid methods- The Next Phase : A Framework For Multi-Product Adoption... Miriam Guest, at AstraZeneca UK and Ulrich Herber at Charles River Full Title: Rapid methods- The Next Phase : A Framework For Multi-Product Adoption Of Rapid Sterility Testing The adoption of rapid sterility testing... 1 year ago | 120 mins The New Annex 1 Revision And The Impact on Using Rapid Methods... Dr. Michael J. Miller, President of Microbiology Consultants, LLC Full Title: The New Annex 1 Revision And The Impact on Using Rapid Methods For Environmental Monitoring EU Annex 1 is getting a tremendous makeover a... 3 years ago | 76 mins MALDI-TOF in the Clinical Lab: Effectiveness and Challenges Elizabeth Palavecino, M.D. Antimicrobial resistance is rising, prompting clinical laboratories to find effective solutions for fast, accurate microorganism identification. MALDI... 4 years ago | 65 mins
